Regeneron (REGN) Tops Q3 EPS by 33c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Regeneron Reports Third Quarter 2015 Financial and Operating Results
November 4, 2015 6:30 AM ESTTARRYTOWN, N.Y., Nov. 4, 2015 /PRNewswire/ --Â Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)Â today announced financial results for the third quarter of 2015 and provided an update on development programs.
Financial Highlights
($ in millions, except per share data)
Three Months... More
